Josef Brueggen
- Molecular Biology top 5%
- Oncology top 5%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 10%
- Endocrinology, Diabetes and Metabolism top 5%
- Co-authors
- Pascal FuretDoriano FabbroChristian SchnellPatrick ChêneChristine FritschAlain De PoverMarjo SimonenWilliam R. Sellers
- Topics
- ATP Synthase and ATPases Research (3 papers)HER2/EGFR in Cancer Research (3 papers)Heat shock proteins research (3 papers)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Josef Brueggen
14 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Molecular Biology 1.8k
- Oncology 633
- Cancer Research 381
- Pulmonary and Respiratory Medicine 348
- Endocrinology, Diabetes and Metabolism 255
Countries citing papers authored by Josef Brueggen
This map shows the geographic impact of Josef Brueggen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josef Brueggen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josef Brueggen more than expected).
Fields of papers citing papers by Josef Brueggen
This network shows the impact of papers produced by Josef Brueggen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josef Brueggen. The network helps show where Josef Brueggen may publish in the future.
Co-authorship network of co-authors of Josef Brueggen
This figure shows the co-authorship network connecting the top 25 collaborators of Josef Brueggen. A scholar is included among the top collaborators of Josef Brueggen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josef Brueggen. Josef Brueggen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 378 | |
| 2 | 50 | |
| 3 | 11 | |
| 4 | Abstract #5649: Pharmakokinetic/phamacodynamic relationship of the HSP90 inhibitor NVP-AUY922 in human xenografts and patients in a clinical Phase I trial | 2 |
| 5 | Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activitybreakdown → | 954 |
| 6 | 189 | |
| 7 | Pharmacological profile of the FLT3-Tyrosine Kinase Inhibitor AST487 | 1 |
| 8 | 48 | |
| 9 | 45 | |
| 10 | 20 | |
| 11 | 1 | |
| 12 | A PK-PD dose optimization strategy for the microtubule stabilizing agent ABJ879 | 1 |
| 13 | 447 | |
| 14 | 268 |
About Josef Brueggen
Josef Brueggen is a scholar working on Hematology, Genetics and Oncology, having authored 14 papers that have together received 2.4k indexed citations. Recurring topics across this work include ATP Synthase and ATPases Research (3 papers), HER2/EGFR in Cancer Research (3 papers) and Heat shock proteins research (3 papers). The work is most often cited by research in Molecular Biology (1.8k citations), Cancer Research (381 citations) and Oncology (633 citations). Josef Brueggen has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Pascal Furet, Doriano Fabbro, Christian Schnell, Patrick Chêne, Christine Fritsch, Alain De Pover, Marjo Simonen, William R. Sellers, Daniela Gabriel and Peter M. Finan. Their work appears in journals such as Journal of Clinical Oncology, Cancer Cell and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.